Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000903423-13-000558
Filing Date
2013-10-25
Accepted
2013-10-25 19:56:49
Documents
2
Period of Report
2013-10-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT dyuksaerie_f3.html 3  
1 OWNERSHIP DOCUMENT dyuksaerie_f3.xml 3 3622
2 duykpoa.htm EX-24 2227
  Complete submission text file 0000903423-13-000558.txt   7255
Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
DUYK GEOFFREY M (Reporting) CIK: 0001202090 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36152 | Film No.: 131171837

Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Issuer) CIK: 0001337553 (see all company filings)

EIN.: 203109565 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)